Global Aptamers Market to Reach USD 4.38 Billion by 2031 Amid Diagnostic and Therapeutic Innovation

[San Diego, 4th June 2025] – Clearview Market Insights (CVMI) projects that the global aptamers market will grow from USD 1.52 billion in 2024 to USD 4.38 billion by 2031, achieving a compound annual growth rate (CAGR) of 16.3 percent. This strong outlook is supported by accelerating adoption in diagnostics, the rise of nucleic-acid therapeutics, and technological breakthroughs in aptamer discovery and modification.

"Aptamers offer a next-generation alternative to antibodies across diagnostics, therapeutics, and biosensors,” said Dr. Nicole Haider, senior molecular biology analyst at CVMI. “With AI-driven SELEX, nanotechnology convergence, and biosafety-grade modifications, aptamers are stepping into the biotech mainstream."

Request Sample @ https://clearviewmarketinsights.com/report-details/global-aptamers-market/

Key Numbers

  • 2024 Market Value: USD 1.52 billion
  • 2031 Market Value: USD 4.38 billion
  • Seven-Year CAGR: 16.3 percent
  • DNA Aptamers Share (2024): 48%
  • North America Market Share: 44%

Market Drivers

  • Oncology and infectious disease diagnostics
  • Chemical versatility and low immunogenicity
  • Growth in AI and high-throughput aptamer screening
  • Strong research pipelines in targeted delivery and biosensors

Company Highlights

  • SomaLogic expanded proteomic applications to over 7,000 protein targets.
  • Base Pair Biotechnologies launched AI discovery tools for aptamer affinity profiling.
  • Aptamer Group formed alliances with cell therapy developers.
  • NeoVentures deployed aptamer-based rapid test kits in food safety and agriculture.

Regional Insights

  • North America: Leads in therapeutic R&D and diagnostics adoption.
  • Asia-Pacific: Fastest-growing region with rising investment in precision medicine.
  • Europe: Focused on academic collaborations and diagnostic biosensor validation.
  • LATAM & MEA: Opportunities emerging in food safety and portable diagnostics.

2024–2025 Milestones

Quarter

Event

Outcome

Q1 2024

Base Pair debuts AI SELEX tool

Shortens lead identification by 35%

Q2 2024

WHO trials aptamer diagnostics for dengue

Positive early results in 3 countries

Q3 2024

SomaLogic expands SOMAscan diagnostic use

Validated for cardiac biomarkers

Q1 2025

Aptamer Group signs CAR-T targeting partnership

Therapeutic aptamer market entry confirmed

 

 

 

 

For more insights, visit https://clearviewmarketinsights.com/

 

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

 

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369

0
Sponsor
V
Zoeken
Sponsor
V
Sponsor
V
Sponsor
V
Suggestions

Other
Pet Supplement Market Scenario: Current State and Future Opportunities
The pet supplement market has undergone significant transformation over the past decade, evolving...
By aaravkadam 0 2K
Other
Trifola Farms CBD Gummies Feel Relaxed and Energized Every Day !
Click Here To Visit Trifola Farms CBD Gummies – “OFFICIAL WEBSITE” What Are...
By HalleBerry 0 797
Other
Unlocking the Secrets of Seamless Final Mile Delivery Services
In the rapidly evolving world of eCommerce and consumer expectations, the last mile of the...
By tmssoftware 0 272
Food
Indulge in Premium Sherpa Honey: A Pure and Sustainable Source of Sweetness
In a world filled with processed sugars and artificial sweeteners, Premium Sherpa Honey offers a...
By ravensmith 0 2K
Other
Virtual Currency Market Scope and Future Trends
The virtual currency market has grown significantly over the past decade, driven by technological...
By swatiroy 0 772
Sponsor
V
Sponsor
V
Sponsor
V